Patrick Ryan, OHDSI Honored by FDA’s Reagan-Udall Foundation


Congratulations to Patrick Ryan, PhD, who’s work with the OHDSI community in real world data analytics has been recognized by the FDA’s Reagan-Udall Foundation. Patrick, who received the Healthcare Innovation Award, was honored alongside Janet Woodcock, MD, Director of the FDA’s Center for Drug Evaluation and Research, at a gala event in Washington, DC. Guest speakers, including FDA Commissioner Scott Gottlieb and Aevi CSO Garry Neil, commended the award winners and OHDSI was highlighted for its innovative developments in real world data. Dr. Woodcock acknowledged the OHDSI community’s continuous contributions to medical decision-making during her own award acceptance. During his discussion, Patrick highlighted the importance of cross-sector collaboration in improving evidence generation and improving health outcomes for patients.

Patrick works as Senior Director of Epidemiology Analytics at Janssen Research and Development and Assistant Professor at the Department of Biomedical Informatics at Columbia University Medical Center. As a seasoned OHDSI collaborator, Patrick has been working side-by-side with top minds from industry, academia and government to advance data sciences and develop rigorous methods for large-scale analysis.

The Reagan-Udall Foundation is an independent nonprofit created by Congress to help the U.S. Food and Drug Administration modernize regulatory science and advance the FDA’s mission. The Healthcare Innovation Award is intended to recognize efforts to advance regulatory science through novel initiatives, including real-world data and use of observational data for active surveillance, population health and medical product safety.